## SYK: Stryker Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -2.8% below STRENGTH zone (3.0-6.0%); PEG 1.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($338.11)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Stryker declares an $0.88 per share quarterly dividend**
- Source: GlobeNewswire | 20251211T130238 | Bullish | Relevance: 99%
- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share, payable on January 30, 2026, to shareholders of record on December 31, 2025. This dividend represents a 4.8% increase compared to the prior year and previous quarter, reflecting the company's confidence in its financial performance and capital allocation strategy.

**2. Citi Maintains Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $420**
- Source: 富途牛牛 | 20251211T190903 | Bullish | Relevance: 99%
-  Citi analyst Joanne Wuensch has maintained a Buy rating on Stryker Corp (SYK.US) and set a target price of $420. The analyst has a 58.6% success rate and a 5.2% average return over the past year, according to TipRanks data. This information is intended for informational purposes only and does not constitute investment advice.

**3. Stryker (NYSE: SYK) boosts dividend 4.8% to $0.88, payable Jan. 30, 2026 to shareholders of**
- Source: Stock Titan | 20251211T130238 | Bullish | Relevance: 99%
-  Stryker (NYSE: SYK) has announced a 4.8% increase in its quarterly dividend, raising it to $0.88 per share. This dividend is payable on January 30, 2026, to shareholders of record as of December 31, 2025. The company stated this increase is consistent with its capital allocation priorities and reflects confidence in its future financial performance.

**4. Stryker Corporation Declares Quarterly Dividend, Payable on January 30, 2026**
- Source: marketscreener.com | 20251211T152833 | Bullish | Relevance: 99%
- Stryker Corporation announced a quarterly dividend of $0.88 per share, payable on January 30, 2026, to shareholders of record as of December 31, 2025. This dividend represents a 4.8% increase compared to the previous year and quarter. The medical equipment company continues its commitment to returning value to shareholders.

**5. The Manufacturers Life Insurance Company Purchases 88,423 Shares of Stryker Corporation $SYK**
- Source: MarketBeat | 20251211T140247 | Somewhat-Bullish | Relevance: 98%
-  The Manufacturers Life Insurance Company increased its stake in Stryker Corporation by 7.5% in Q2, acquiring 88,423 shares to hold a total of 1,271,247 shares valued at approximately $502.9 million. Institutional investors now own about 77.09% of Stryker's stock, with a "Moderate Buy" consensus rating and a $433.78 average target price. This comes despite recent insider selling, which totaled 522,118 shares in the past three months.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Citigroup | $420 | $455 | -8% |
| 2025-11-14 | Truist Securiti | $400 | $392 | +2% |
| 2025-11-14 | Wells Fargo | $456 | $452 | +1% |
| 2025-11-14 | Needham | $448 | $448 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Citigroup | main | Buy |
| 2025-11-14 | Truist Securiti | main | Hold |
| 2025-11-14 | Wells Fargo | main | Overweight |
| 2025-11-14 | Needham | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($34.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (+0.8%)
- Blackrock Inc.: 7.0% (+0.4%)
- JPMORGAN CHASE & CO: 6.2% (+95.3%)
- Greenleaf Trust: 4.3% (-0.3%)
- State Street Corpora: 3.9% (-0.1%)

### Key Risks

1. Heavy insider selling: $35M sold (6 transactions in 90 days).
2. Long-term trend broken: trading 6.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.86 elevated, pricing in significant growth expectations. Forward P/E 23.6x stretched relative to 10% growth. Balance sheet: $1.4B free cash flow. Insider selling cluster ($34.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $135.0B |
| Beta | 0.90 |
| 52W Range | $329.16 - $406.19 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.86 |
| Forward P/E | 23.6 |
| Current P/E | 26.1 |
| YoY Growth | 10.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -2.8% (minimal 5-day change). Below STRENGTH zone by 5.8pp (needs >3.0% for momentum thesis). Below SMA200 (0.94x), long-term trend not supportive. MACD histogram bearish (-1.63), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.75% (CS: 11) | Weak |
| RSI_14 | 39.1 | Neutral |
| MACD Histogram | -1.63 | Bearish |
| vs SMA20 | 0.970x | Below |
| vs SMA50 | 0.962x | Below |
| vs SMA200 | 0.938x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $352.97
- **Stop Loss:** $338.11 (4.2% risk)
- **Target:** $367.83 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 92
- **Position Value:** $32,473.24
- **Portfolio %:** 32.47%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-27 (Est: $4.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.13 | $3.19 | +1.9% |
| 2025Q2 | $3.07 | $3.13 | +1.9% |
| 2025Q1 | $2.73 | $2.84 | +4.0% |
| 2024Q4 | $3.87 | $4.01 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*